QUICKLINKS AND VIEW OPITONS
There were five suicides among study participants given Acomplia (rimonobant)
Thursday, October 23, 2008 12:09 pm Email this article
"Between June and August 2008, BBC News reported, there were five suicides among clinical trial participants taking the drug, compared to one suicide among participants taking a placebo," Forbes reported.
My guess is that this is the reason why that Merck stopped development of taranabant. My guess is that there were several suicides in people given the drug. I can't imagine them stopping development for any other reason. REFERENCE
. Forbes. 2008 Oct 23.
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.